Federal Register / Vol. 86, No. 15 / Tuesday, January 26, 2021 / Notices 7097 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–01621 Filed 1–25–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day-21–21CH; Docket No. CDC–2021– 

0005] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Serological Assay Development: 

Brucella spp. Rough Strains. This 

proposed collection will involve 

specimen collection and relevant 

clinical information from individuals 

exposed to rough strains of Brucella 

spp., or cases of brucellosis due to 

infection with rough strains of Brucella 

spp. 

DATES: CDC must receive written 

comments on or before March 29, 2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0005 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

Serological Assay Development: 

Brucella spp. Rough Strains—New— 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Brucellosis is a zoonotic disease 

caused by Brucella spp., which are 

Gram-negative, intracellular bacterial 

pathogens. Annually, 500,000 human 

cases of brucellosis occur worldwide. 

Though isolation of the organism can 

help identify the causative species of 

infection, this method is not always 

possible due to laboratory biosafety 

capacity requirements and specimen 

availability. In some of these instances, 

serological methods are helpful for 

diagnosis. Serial serological methods are 

also useful for monitoring individuals 

who have had known exposures to 

smooth Brucella spp. for 

seroconversion, which can help detect 

potential infection and reduce time to 

diagnosis and treatment. 

The proposed data collection will 

help to understand the frequency of 

exposures to rough strain Brucella spp. 

in the United States, identify specific 

antigens associated with rough strain 

Brucella infections, develop highsensitivity and high-specificity 

serological diagnostic assays based on 

recognition of these antigens, and to 

better understand the human humoral 

immune response to rough Brucella 

strains. Data collected will be used to 

create a bank of specimens to help 

develop additional tools for safer and 

more timely diagnosis of brucellosis 

caused by rough strains of Brucella spp. 

CDC will collect specimens and 

medical/surveillance record abstractions 

from individuals exposed to rough 

strains of Brucella spp., and individuals 

with confirmed diagnosis of brucellosis 

as a result of infection from rough 

strains of Brucella spp. 

CDC requests approval for three years. 

The estimated annualized burden hours 

are 55. There is no cost to respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Patient (specimen collection) ............ N/A ................................................... 10 1 5 50 

7098 Federal Register / Vol. 86, No. 15 / Tuesday, January 26, 2021 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Health department ............................ Clinical/exposure information ........... 10 1 0.5 5 

Total ........................................... 55 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–01622 Filed 1–25–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–21BZ; Docket No. CDC–2021– 

0006] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

request for emergency clearance of the 

information collection titled 

Requirement for Proof of Negative 

Covid-19 Test Result for All Airline 

Passengers Arriving into The United 

States from The United Kingdom. This 

collection accompanies a CDC Order of 

the same name, and is designed to 

ensure public health authorities in the 

United States can confirm that 

individuals have received a negative test 

result for COVID–19 prior to departing 

the United Kingdom and arriving in the 

United States. 

DATES: CDC must receive written 

comments on or before March 29, 2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0006 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, of 

the Information Collection Review 

Office, Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

Requirement for Proof of Negative 

COVID–19 test result for all airline 

passengers arriving into the United 

States from the United Kingdom— 

New—National Center for Emerging 

Zoonotic and Infectious Diseases 

(NCEZID), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

This information collection 

accompanies the Notice and Order 

named above. Pursuant to 42 CFR 71.20 

and as set forth in greater detail below, 

this Notice and Order prohibit the 

introduction into the United States of 

any airline passenger departing from the 

UK unless the passenger has a negative 

pre-departure test result for COVID–19. 

The test must be a viral test that was 

conducted on a specimen collected 

during the three calendar days 

preceding the flight’s departure 

(Qualifying Test). Passengers must 

retain written or electronic 

documentation reflecting the negative 

Qualifying Test result presented to the 

airline and produce such results upon 

request to any U.S. government official 

or a cooperating state or local public 

health authority. 

Pursuant to 42 CFR 71.31(b) and as set 

forth in greater detail below, this Notice 

and Order constitutes a controlled free 

pratique to any airline with an aircraft 

arriving into the United States from the 

UK. Pursuant to the controlled free 

pratique, the airline must comply with 

the following conditions in order to 

receive permission for the aircraft to 

enter and disembark passengers in the 

United States: